Healthcare -
Biotechnology - NASDAQ - US
$ 276.8944
-0.0958 %
$ 35.7 B
Market Cap
-105.28
P/E
ALNY - REVENUE
Revenue ALNY - Alnylam Pharmaceuticals, Inc.
1.83 B
LAST VALUE
47.16%
2 YEAR CAGR
89.45%
5 YEAR CAGR
44.16%
10 YEAR CAGR